A former Microsoft employee was sentenced to two years in prison for his part in an insider trading scheme that netted more than $400,000.» Read More
This is the story of the most successful—and least known—whistleblower operation of all time. Four men who have made a vast fortune blowing the whistle on the drug industry, forcing Big Pharma to pay the federal government over a billion dollars in settlements.
ETFs have emerged as a possible mechanism for maximizing gains in one stock while potentially masking trading patterns, people familiar with the matter told the FT.
Bradley Birkenfeld once lived the high life as secret Swiss banker at UBS in Geneva. Then he delivered some of the world’s best-kept secrets to the US government, expecting a great reward. And now he sits in federal prison in Pennsylvania.
Cheryl Eckard became the largest individual whistleblower award recipient ever, hauling in a $96 million bounty as her reward for providing information to the government about manufacturing problems at GlaxoSmithKline.
Have you ever been tempted to blow the whistle on something suspicious you've witnesses in the workplace? Take our poll and share your opinion.
Forget what you think you know about lone whistleblowers taking on giant corporations all by themselves. These days, there's a cottage industry to support—and profit from—whistleblowing.
When President Barack Obama signed the Dodd-Frank Wall Street reform act into law last summer, very few in the financial industry knew that the bill included a massive change in the way whistleblowing law works in this country.
Some Wall Street lawyers have been lobbying Congress to get more money for the Securities and Exchange Commission, which faces a budget freeze. The New York Times reports.
That promise of cash is providing a new incentive for employees to reveal wrongdoing in their companies. What would you do?
Wall Street is suddenly paying attention to the culture of whistleblowing, because the new Dodd-Frank financial reform law, for the first time, extends whistleblower provisions to Wall Street, meaning employees who expose fraud and wrongdoing stand to collect between 10 and 30 percent of the amount recovered by the government.
Taking a look at the biggest fraud cases of all time, and you're left with just one question: What's wrong with the pharmaceutical industry?
A former technology consultant jailed in the federal crackdown on insider trading at hedge funds called Business Insider early this morning to ask for help finding a lawyer.
Julian Assange has signed book deals worth more than £1 million ($1.5 million) in the US and UK, to allow the WikiLeaks founder to cover his legal fees and maintain the whistleblowing site, reports the Financial Times.
Luring investors into a stock market trap, taking money from hedge funds, pumping stocks, helping investment banks fund a liquidity crisis, being a team player for Wall Street - quite a lot of nefarious things for me to have foisted upon CNBC in just six months! No wonder its felt so hectic. Gary Anderson has written a 2000-word attack on CNBC titled Why Is CNBC Trying So Hard To Defend Insider Trading? But, for the most part, it is about John Carney.
The Wall Street Journal has revealed the identity of the government's cooperating witness CW-2.
Although it was the Department of Justice and the FBI that took the lead on four insider-trading arrests Thursday, the Securities and Exchange Commission is also conducting its own inquiries, the commission's director of enforcement said Friday.
The good news about yesterday's arrests is that federal authorities only arrested people who, if the allegations are correct, are truly bad guys.
No doubt more than a few eyebrows will be cocked when the eyes below them come across Advanced Micro Devices statement that it was the victim of insider trading.